Bertrand William C JR's Form 4 filing
Adaptimmune Therapeutics PLC (ADAPY) · filed Jan 13, 2022
- Accession no.
- 0001104659-22-004153
- Filed
- Jan 13, 2022
- Trade date
- Jan 11-12, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $21.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bertrand William C JRCIK 0001291937 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 11, 2022 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −3,770 | $3.56 | −$13,421.2 | 6,343 | Direct | |
| Jan 12, 2022 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −2,248 | $3.54 | −$7,957.92 | 3,754 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.